Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $7.17 down -0.55% from its previous closing price of $7.21. In other words, the price has decreased by -$0.55 from its previous closing price. On the day, 2.06 million shares were traded. AMRX stock price reached its highest trading level at $7.29 during the session, while it also had its lowest trading level at $7.105.
Ratios:
For a deeper understanding of Amneal Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.57. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on February 24, 2025, Upgraded its rating to Overweight and sets its target price to $12 from $9 previously.
On September 06, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 01 ’25 when Patel Gautam sold 80,000 shares for $8.30 per share. The transaction valued at 664,000 led to the insider holds 1,728,886 shares of the business.
Patel Tushar Bhikhubhai sold 5,000,000 shares of AMRX for $41,750,000 on Mar 14 ’25. The 10% Owner now owns 48,578,209 shares after completing the transaction at $8.35 per share. On Mar 14 ’25, another insider, Patel Tushar Bhikhubhai, who serves as the 10% Owner of the company, bought 5,000,000 shares for $8.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 3337627904 and an Enterprise Value of 4767906816. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.80. Its current Enterprise Value per Revenue stands at 1.707 whereas that against EBITDA is 8.156.
Stock Price History:
The Beta on a monthly basis for AMRX is 1.20, which has changed by 0.31318676 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, AMRX has reached a high of $9.48, while it has fallen to a 52-week low of $5.18. The 50-Day Moving Average of the stock is -12.32%, while the 200-Day Moving Average is calculated to be -11.81%.
Shares Statistics:
For the past three months, AMRX has traded an average of 1.72M shares per day and 2274420 over the past ten days. A total of 309.88M shares are outstanding, with a floating share count of 137.45M. Insiders hold about 56.14% of the company’s shares, while institutions hold 36.64% stake in the company. Shares short for AMRX as of 1743379200 were 4429620 with a Short Ratio of 2.58, compared to 1740700800 on 2763581. Therefore, it implies a Short% of Shares Outstanding of 4429620 and a Short% of Float of 2.1999999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
